Opioid Use Disorder Retrospective Study

Principal Investigator: Andrew Herring, M.D.

Funder: Clinical Trials Networks/National Institute on Drug Abuse

Developed from an initial grant at the Levitt Center, the opioid treatment program established by Dr. Herring's EDBRIDGE grant is now available at over 52 hospitals in California.  To disseminate the impact of ED-initiated buprenorphine treatment to the broader academic and scientific communities, Dr. Herring and his team have begun work on a large retrospective study of all of the patients who received buprenorphine in Highland Hospital’s emergency department in 2018. With over 400 of the 650 eligible charts reviewed, the depth and magnitude of this retrospective study will reflect the trailblazing approach Dr. Herring and other providers at Highland have taken to initiate treatment for opioid addiction in the ED.